PGAD: when the body signals arousal that nobody asked for.

Persistent genital arousal disorder is one of the most isolating conditions in medicine, and one where the nervous system's role is finally being taken seriously.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What persistent genital arousal disorder is

Persistent genital arousal disorder, or PGAD, is a condition in which the physical sensations of sexual arousal, such as genital swelling, tingling, throbbing, pulsing or a sense of being on the edge of orgasm, occur persistently and without any sexual desire or stimulation. The sensations are unwanted and intrusive, often painful, and orgasm brings little or no relief. Newer terminology calls it PGAD/GPD, adding 'genito-pelvic dysesthesia' to capture the fact that many people experience the sensations as abnormal, uncomfortable or painful rather than pleasurable.

It mostly affects women, though men are affected too. People with PGAD describe shame, difficulty concentrating, trouble sleeping, avoiding relationships and, in many cases, thoughts of suicide. Despite that, it is often dismissed or joked about. Medical evaluation looks for contributing factors such as Tarlov cysts on the sacral nerves, pelvic floor muscle tension, pudendal nerve irritation, medication effects (particularly starting or stopping certain antidepressants) and vascular problems. In many cases no clear physical cause is found.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system rather than by ongoing damage or disease in the body. The nervous system has become a sensitised alarm, and in PGAD the alarm is wired into the circuits that produce genital sensation and arousal. The sensations are not imaginary, not a sign of a hidden desire, and not 'all in your head' in the dismissive sense. Because the brain can change, they are reversible.

The ATNS Index of Neuroplastic Symptoms recommends assessment for neuroplastic symptoms in PGAD. The condition fits the neuroplastic pattern in several ways:

• Genital arousal is normally produced by the nervous system in response to context. In PGAD the system has learned to produce the output without the input, much as chronic pain produces pain without injury.
• Attention and fear act as amplifiers. The more intrusive and shameful the sensation, the more the brain monitors it, and the more it monitors, the stronger the signal becomes.
• Stress, anxiety and trauma are very common in people with PGAD, and the condition often begins or worsens during periods of emotional strain.

Where a physical contributor is found, such as a Tarlov cyst or a medication effect, it should be addressed. Even then, a sensitised nervous system frequently keeps the symptom going and benefits from direct attention. Our central sensitization explainer describes the mechanism in more depth.

What the research shows

A systematic review of PGAD research from 2015 to 2025, covering 14 studies, maps what is known about diagnosis, causes and treatment. It describes a range of proposed contributors, from sacral nerve root cysts and pelvic floor dysfunction to medication effects, and reports one brain imaging study showing altered resting-state connectivity, the closest the field has come to a central mechanism. The overall evidence is thin and mostly from small studies.

A scoping review of treatment in PGAD found a scarcity of systematic research and concluded that both physical and psychiatric concerns need addressing. It reported that approaches incorporating cognitive behavioural therapy, mindfulness and patient education were effective in the studies available, and it gathered patient accounts describing shame, suicidal thoughts, isolation and poor sleep.

A registry study of people with PGAD/GPD found that almost 70 percent had a co-occurring psychiatric condition, most often depression, and that in the majority no clear physical cause was identified. A case report of psychological treatment using an integrated approach of cognitive behavioural therapy, mindfulness and emotion skills recorded reductions in catastrophising, anxiety and depression and better quality of life. A single case is weak evidence, but it illustrates the direction the ATNS index recommends. No study has tested a formal pain-reprocessing approach in PGAD, so the rationale is drawn from the broader literature on sensitised pelvic symptoms.

Signs the brain may be part of the picture

• Gynaecological, neurological and pelvic examinations are normal, or findings such as a small Tarlov cyst are of uncertain significance.
• Symptoms fluctuate with stress, anxiety, conflict or fatigue, and may ease when you are deeply absorbed in something.
• Paying attention to the sensation makes it stronger; distraction weakens it.
• Onset followed a stressful period, a medication change, a frightening sexual or medical experience, or trauma.
• You also have pelvic pain, bladder urgency, IBS, restless legs, anxiety or other symptoms that tests could not explain.

A solution that addresses it

There is an approach that addresses the brain's contribution. It is often called pain and symptom reprocessing. It includes education about neuroplastic symptoms, somatic tracking (observing the sensation with curiosity and safety rather than dread or shame), reducing fear and threat around symptoms, a graded return to normal activity and intimacy, emotional awareness and expression, and acceptance and commitment skills. It is delivered by trained clinicians, works alongside pelvic floor physiotherapy and medical care, and is increasingly available through digital programs.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If you are living with PGAD and have felt alone with it, you can join the waitlist.

What to do next

Find a clinician who takes PGAD seriously, such as a sexual medicine specialist, a pelvic pain clinic or a urogynaecologist. Ask about evaluation for pelvic floor tension, nerve irritation, sacral cysts and medication effects. Do not stop or change any medication, especially antidepressants, without your prescriber's guidance, since abrupt changes can trigger or worsen symptoms. If you have thoughts of suicide, seek help immediately from emergency services or a crisis line; this is a known and serious part of PGAD and you deserve support.

Once physical contributors have been assessed, ask whether your symptoms fit a neuroplastic pattern. If they might, start learning and practising. The chronic pelvic pain and ACT page and the somatic practices page are good places to begin.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.